TSG may also act as an effective neuroprotective agent against PD through the modulation of the PI3K/Akt signaling pathway and ROS-mediated JNK, p38, and mitochondrial pathways [69–71, 80] (Table 3). Here, AKT1 is linked to Parkinson disease.